 |
Novartis splits drugs business into twoNovartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its current pharma head in the second high-profile management reshuffle this year. More… |
 |
Novartis to sell $13.8bn stake in RocheDrugmaker Novartis aims to dispose of a 13.5 billion Swiss franc ($13.8 billion) stake in its local rival Roche and has already hired banks to support the selling process, a Swiss paper reported on Sunday. The world's biggest More… |
|
Novartis to sell $13.8bn stake in RocheDrugmaker Novartis aims to dispose of a 13.5 billion Swiss franc ($13.8 billion) stake in its local rival Roche and has already hired banks to support the selling process, a Swiss paper reported on Sunday. The world's biggest More… |
 |
Novartis probing $85m bribery charges in TurkeyAn anonymous whistleblower has accused Swiss drugmaker Novartis of paying bribes in Turkey through a consulting firm to secure business advantages worth an estimated $85 million, according to a Feb. 17 email seen by Reuters. The a More… |
 |
Novartis’ new heart failure medicine gets FDA approvalNovartis’ new heart failure medicine Entresto (sacubitril/valsartan) tablets, previously known as LCZ696, has been approved by the US Food and Drug Administration (FDA). Entresto will be available on prescription for patient More… |
 |
GSK, Novartis complete $20bn asset swap dealsGlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers. GSK is forming a consumer health joint venture with Novartis, while at the same More… |
 |
Novartis, Google to develop 'smart' contact lensSwiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics track their blood glucose levels or restore the eye's ability to focus. The More… |
 |
University of Ain Shams opens MS treatment unitThe University of Ain Shams, in cooperation with Novartis Pharmaceuticals, has opened Egypt’s first medical unit for the treatment of multiple sclerosis (MS). An autoimmune disease that affects the central nervous system, MS More… |
|
University of Ain Shams opens MS treatment unitThe University of Ain Shams, in cooperation with Novartis Pharmaceuticals, has opened Egypt’s first medical unit for the treatment of multiple sclerosis (MS). An autoimmune disease that affects the central nervous system, MS More… |
 |
40pc of UAE adults ‘have hypertension’About 40.8 per cent of UAE nationals in the age group of 35-70 years suffer from hypertension or high blood pressure, according to a recent survey conducted by the Dubai Health Authority (DHA). Hypertension is the leading cause of More… |
